Microbot Medical (MBOT) Change in Accured Expenses (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Change in Accured Expenses data on file, last reported at $384000.0 in Q1 2026.

• Quarterly Change in Accured Expenses rose 162.24% year-over-year to $384000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 136.71% YoY) and the FY2025 annual result came in at $495000.0, down 43.3% from the prior year.
• Change in Accured Expenses retreated to $384000.0 in Q1 2026, from $506000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.0 million in Q4 2024 to a low of -$900000.0 in Q1 2023.
• A 5-year average of $48705.9 and a median of $55000.0 in 2023 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 1920.0% — and 2025, when it soared 6545.45%.
• Tracing MBOT's Change in Accured Expenses over 5 years: stood at $416000.0 in 2022, then sank by 86.78% to $55000.0 in 2023, then soared by 1807.27% to $1.0 million in 2024, then sank by 51.76% to $506000.0 in 2025, then declined by 24.11% to $384000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $384000.0 (Q1 2026), $506000.0 (Q4 2025), and -$103000.0 (Q3 2025), per Business Quant data.